Proceeding report of the Fourth Symposium on Hidradenitis Suppurativa Advances 2019.

CAM CO(2) laser HISTORIC, Hidradenitis Suppurativa Core Outcomes Set International Collaboration HS PROGRESS IDEOM Nd:YAG THESEUS clinical trials dermcidin epigenetics fibroblasts hidradenitis suppurativa interleukins medical cannabis metabolome microbiome pain management sinus tracts wound care

Journal

Journal of the American Academy of Dermatology
ISSN: 1097-6787
Titre abrégé: J Am Acad Dermatol
Pays: United States
ID NLM: 7907132

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 18 02 2020
revised: 20 05 2020
accepted: 25 05 2020
pubmed: 5 6 2020
medline: 1 6 2021
entrez: 5 6 2020
Statut: ppublish

Résumé

The Fourth Annual Symposium on Hidradenitis Suppurativa (SHSA) took place on November 1-3, 2019, at the Westin Book Cadillac Hotel in Detroit, Michigan. This symposium was a joint meeting of the US Hidradenitis Suppurativa Foundation and the Canadian Hidradenitis Suppurativa Foundation. This cross-disciplinary meeting with experts from around the world was an opportunity to discuss the most recent advances in the study of hidradenitis suppurativa (HS) pathogenesis, clinical trials, classification, scoring systems, complementary/alternative medical treatments, diet, pain management, surgical and laser treatment, and ultrasonographic assessment. A special preconference workshop was held on the use of neodymium-doped yttrium-aluminum-garnet laser hair reduction, sinus tract deroofing, and carbon dioxide laser excision with ultrasonographic mapping and tumescent anesthesia for the treatment of HS. The focused workshops on establishing an HS clinic, setting up an HS support group, the Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository, and wound care were held during the meeting. A special program called HS Ambassadors was established for patients who may have questions about the conference presentations, and in addition, a meet and greet for patients and HS Ambassadors was arranged. To facilitate networking between those early in their careers and clinical and research experts, a mentoring reception was held.

Identifiants

pubmed: 32497690
pii: S0190-9622(20)30989-0
doi: 10.1016/j.jaad.2020.05.114
pii:
doi:

Types de publication

Congress

Langues

eng

Sous-ensembles de citation

IM

Pagination

120-129

Subventions

Organisme : NIAMS NIH HHS
ID : R13 AR076260
Pays : United States

Informations de copyright

Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Shanthi Narla (S)

Department of Dermatology, Henry Ford Health System, Detroit, Michigan. Electronic address: shanthi.narla1@gmail.com.

Kyla N Price (KN)

University of Illinois College of Medicine, Chicago, Illinois.

Muskaan Sachdeva (M)

Faculty of Medicine, University of Toronto, Toronto, Canada.

Monica Shah (M)

Faculty of Medicine, University of Toronto, Toronto, Canada.

Vivian Shi (V)

Division of Dermatology, Department of Medicine, University of Arizona, Tucson, Arizona.

Iltefat Hamzavi (I)

Department of Dermatology, Henry Ford Health System, Detroit, Michigan.

Afsaneh Alavi (A)

Division of Dermatology, University of Toronto, Women's College Hospital, Toronto, Canada.

Michelle A Lowes (MA)

The Rockefeller University, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH